DOCS 클래스 A Doximity, Inc. Class A Common Stock
NYSE · Health Care · SEC EDGAR에서 보기 ↗ 10-K/10-Q 8월 6, 2026DOCS 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
DOCS 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
막대 세분성은 선택한 기간에 따라 조정됩니다. 막대의 시가/고가/저가/종가를 보려면 차트에 마우스를 올리세요.
Doximity, Inc. Class A Common Stock 정보 위키백과 회사 개요
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck. In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California. By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list. In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year. In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones. In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. At the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site. In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million. Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones. In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries. In February 2022, Doximity acquired Amion, an on-call doctor scheduling company. In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
출처: 위키백과 (영어), CC BY-SA 4.0 · 위키백과에서 보기 ↗
10년 성과 매출, 순이익, 마진 및 EPS 추세
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
| 지표 | 5년 추세 | DOCS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| P/E (TTM) | 39.85년 평균 ≈49.8 | ≈49.8 | · | · | |
| P/S (TTM) | 9.25년 평균 ≈16.1 | ≈16.1 | · | · | |
| P/B (MRQ) | 6.65년 평균 ≈7.6 | ≈7.6 | · | · | |
| Price / FCF (주가 / FCF) | 18.75년 평균 ≈39.2 | ≈39.2 | · | · | |
| Price / Cash Flow (주가 / 현금 흐름) | 18.75년 평균 ≈38.9 | ≈38.9 | · | · | |
| 주가 / 유형 장부 가치 (MRQ) | 6.85년 평균 ≈8.3 | ≈8.3 | · | · | |
| PEG Ratio (PEG 비율) | ≈1.2 | · | · | · |
동종 기업 중앙값은 지표별로 표준화된 기준으로 계산되며, 이 주식에 표시된 TTM/MRQ 기준과 항상 일치하지 않을 수 있습니다.
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
| 지표 | 5년 추세 | DOCS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 매출 총이익률 (TTM) | 88.1%5년 평균 ≈88.9% | ≈88.9% | · | · | |
| 영업이익률 (TTM) | 29.6%5년 평균 ≈34.1% | ≈34.1% | · | · | |
| EBITDA 마진 (TTM) | 32.0%5년 평균 ≈36.2% | ≈36.2% | · | · | |
| 세전 마진 (TTM) | 34.5%5년 평균 ≈37.8% | ≈37.8% | · | · | |
| 순이익률 (TTM) | 25.5%5년 평균 ≈34.5% | ≈34.5% | · | · | |
| ROA (TTM) | 14.6%5년 평균 ≈16.9% | ≈16.9% | · | · | |
| ROE (TTM) | 17.2%5년 평균 ≈17.4% | ≈17.4% | · | · | |
| ROIC | 17.7%5년 평균 ≈15.7% | ≈15.7% | · | · |
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
| 지표 | 5년 추세 | DOCS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| 유동비율 (MRQ) | 6.15년 평균 ≈6.9 | ≈6.9 | · | · | |
| Quick Ratio (당좌 비율) | 2.35년 평균 ≈1.9 | ≈1.9 | · | · |
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
| 지표 | 5년 추세 | DOCS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Revenue YoY (매출 YoY) | 13.1%5년 평균 ≈26.9% | ≈26.9% | · | · | |
| Revenue CAGR 3Y (매출 CAGR 3년) | 15.4%5년 평균 ≈21.9% | ≈21.9% | · | · | |
| Revenue CAGR 5Y (매출 CAGR 5년) | 25.5% | · | · | · | |
| EPS YoY | -11.7%5년 평균 ≈51.7% | ≈51.7% | · | · | |
| Net Income YoY (순이익 YoY) | -12.2%5년 평균 ≈50.2% | ≈50.2% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3년) | 22.7%5년 평균 ≈28.5% | ≈28.5% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5년) | 33.6% | · | · | · | |
| Net Income CAGR 3Y (순이익 CAGR 3년) | 20.2%5년 평균 ≈25.5% | ≈25.5% | · | · | |
| Net Income CAGR 5Y (순이익 CAGR 5년) | 31.3% | · | · | · |
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
| 지표 | 5년 추세 | DOCS | 5년 평균 | 동종업계 중앙값 | 결론 |
|---|---|---|---|---|---|
| Asset Turnover (자산 회전율) | 0.55년 평균 ≈0.5 | ≈0.5 | · | · | |
| Receivables Turnover (매출 채권 회전율) | 4.75년 평균 ≈4.8 | ≈4.8 | · | · | |
| Revenue / Employee (연간 매출액 ÷ 직원 수(yfinance 보고 인원수). 파생 — 저장된 SEC-XBRL 개념이 아님.) | ≈$732.8K | · | · | · |
가치 · ≈ 5년 평균 · 산업 중앙값 · 중앙값 대비 평가
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
| 기간 | 보고서 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|---|
| 2026년 6월 30일 | $0.29 | $0.31 | -6.7% | |
| 2026년 3월 31일 | $0.26 | $0.29 | -10.0% | |
| 2025년 12월 31일 | $0.46 | $0.45 | 1.2% | |
| 2025년 9월 30일 | $0.45 | $0.39 | 16.4% | |
| 2025년 6월 30일 | $0.36 | $0.31 | 17.5% | |
| 2025년 3월 31일 | $0.46 | $0.45 | 1.2% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
대차대조표
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
현금 흐름
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
수익성
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
유동성 및 지급능력
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
효율성
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
주당
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.19 | $5.73 | $4.83 | $4.98 | $4.57 | · | · | |
| Revenue / Share | $3.24 | $2.83 | $2.31 | $1.96 | $1.80 | · | · | |
| Cash Flow / Share | $1.64 | $1.36 | $0.89 | $0.84 | $0.66 | · | · | |
| Cash / Share | $1.20 | $1.11 | $0.52 | $0.81 | $0.59 | · | · | |
| EPS (TTM) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | · | · |
성장률
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
가치 평가 (TTM)
| 지표 | 추세 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
손익계산서
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | · | 187,478,000 | 187,705,000 | 187,984,000 | · | 187,161,000 | 186,252,000 | 185,610,000 | · | 186,309,000 | 193,112,000 | 194,521,000 | · | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | · | 199,224,000 | 200,745,000 | 201,158,000 | · | 202,233,000 | 200,407,000 | 199,224,000 | · | 200,463,000 | 209,014,000 | 212,355,000 | · | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
대차대조표
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
현금 흐름
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
수익성
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
유동성 및 지급능력
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
효율성
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
주당
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.09 | · | $5.29 | $5.82 | $5.47 | · | $5.50 | $5.15 | $4.92 | · | $4.64 | $4.62 | $5.09 | · | $4.81 | $4.57 | |
| Revenue / Share | $0.82 | · | $0.93 | $0.84 | $0.73 | · | $0.83 | $0.68 | $0.64 | · | $0.67 | $0.54 | $0.51 | · | $0.54 | $0.48 | |
| Cash Flow / Share | $0.22 | · | · | · | $0.31 | · | · | · | $0.21 | · | · | · | $0.27 | · | · | · | |
| Cash / Share | $1.52 | · | $0.35 | $0.90 | $0.73 | · | $0.88 | $0.99 | $0.60 | · | $0.66 | $0.57 | $1.58 | · | $0.71 | $0.38 | |
| EPS (TTM) | $0.84 | · | $1.20 | $1.26 | $1.17 | · | $1.00 | $0.87 | $0.80 | · | $0.67 | $0.59 | $0.56 | · | $0.56 | $0.66 |
가치 평가 (TTM)
| 지표 | 추세 | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $638M | $621M | $590M | · | $550M | $517M | $494M | · | $468M | $448M | $437M | · | $402M | $384M | |
| Net Income TTM | $167M | · | $239M | $253M | $235M | · | $201M | $174M | $161M | · | $138M | $123M | $119M | · | $119M | $141M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 24.7 | · | 36.9 | 58.1 | 52.4 | · | 53.4 | 50.1 | 35.0 | · | 41.9 | 36.0 | 60.8 | · | 59.9 | 45.8 | |
| P/S | 5.7 | · | 12.8 | 22.1 | 19.5 | · | 18.2 | 15.7 | 10.5 | · | 11.1 | 8.9 | 15.2 | · | 16.1 | 15.1 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| Earnings Yield | 4.0% | · | 2.7% | 1.7% | 1.9% | · | 1.9% | 2.0% | 2.9% | · | 2.4% | 2.8% | 1.7% | · | 1.7% | 2.2% |
최신 기간은 왼쪽에 · null 값은 ·로 표시
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
| 지표 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 매출 | $645M | $570M | $475M | $419M | $344M |
| 매출 총이익률 % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| 영업이익률 % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| 순이익 | $196M | $223M | $148M | $113M | $155M |
| 희석 EPS | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
| 지표 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 유동비율 | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| 당좌 비율 | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
| 지표 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| 잉여현금흐름 | $326M | $273M | $184M | $178M | $125M |
기관 투자자 (13F) 420개의 제출자 · $3.4B 전체 · 기준일 2026년 9월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 44 (-51 이전 분기 대비) | 101 (-12 이전 분기 대비) | 132 (-36 이전 분기 대비) | 147 (+21 이전 분기 대비) | +3.0M |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $588,281,276 | 13,285,485 | 17.38% | 주식 |
| BlackRock, Inc. | $296,729,585 | 14,307,116 | 8.76% | 주식 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132,468,433 | 6,387,099 | 3.91% | 주식 |
| VANGUARD CAPITAL MANAGEMENT LLC | $123,971,960 | 5,977,433 | 3.66% | 주식 |
| D. E. Shaw & Co., Inc. | $122,826,179 | 5,922,188 | 3.63% | 주식 |
| TWO SIGMA INVESTMENTS, LP | $96,385,189 | 4,647,309 | 2.85% | 주식 |
| STATE STREET CORP | $87,334,253 | 4,210,909 | 2.58% | 주식 |
| GOLDMAN SACHS GROUP INC | $84,762,882 | 4,086,928 | 2.50% | 주식 |
| GEODE CAPITAL MANAGEMENT, LLC | $79,848,140 | 3,849,310 | 2.36% | 주식 |
| WELLINGTON MANAGEMENT GROUP LLP | $65,022,244 | 3,135,113 | 1.92% | 주식 |
| DEUTSCHE BANK AG\ | $60,011,895 | 2,893,534 | 1.77% | 주식 |
| RENAISSANCE TECHNOLOGIES LLC | $59,184,680 | 2,853,649 | 1.75% | 주식 |
| BNP PARIBAS FINANCIAL MARKETS | $55,840,936 | 2,692,427 | 1.65% | 주식 |
| Carmignac Gestion | $48,861,366 | 2,355,900 | 1.44% | 주식 |
| FEDERATED HERMES, INC. | $48,345,085 | 2,331,007 | 1.43% | 주식 |
| MORGAN STANLEY | $46,575,609 | 2,245,689 | 1.38% | 주식 |
| LOOMIS SAYLES & CO L P | $45,345,771 | 2,186,392 | 1.34% | 주식 |
| Squarepoint Ops LLC | $45,090,336 | 2,174,076 | 1.33% | 주식 |
| MILLENNIUM MANAGEMENT LLC | $42,902,785 | 2,068,601 | 1.27% | 주식 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $42,682,967 | 1,831,887 | 1.26% | 주식 |
| Invesco Ltd. | $39,908,904 | 1,924,248 | 1.18% | 주식 |
| Amundi | $39,467,726 | 1,902,977 | 1.17% | 주식 |
| NORGES BANK | $39,178,461 | 1,889,029 | 1.16% | 주식 |
| AQR CAPITAL MANAGEMENT LLC | $37,860,213 | 1,838,767 | 1.12% | 주식 |
| Gotham Asset Management, LLC | $35,523,762 | 1,712,814 | 1.05% | 주식 |
| CITADEL ADVISORS LLC | $32,385,137 | 1,561,482 | 0.96% | 주식 |
| Iron Triangle Partners LP | $30,401,231 | 686,568 | 0.90% | 주식 |
| AXA Investment Managers S.A. | $29,339,221 | 401,083 | 0.87% | 주식 |
| Walleye Capital LLC | $29,032,972 | 1,399,854 | 0.86% | 주식 |
| Assenagon Asset Management S.A. | $28,857,517 | 1,018,261 | 0.85% | 주식 |
| BANK OF AMERICA CORP /DE/ | $28,029,302 | 1,351,461 | 0.83% | 주식 |
| Qube Research & Technologies Ltd | $26,585,445 | 1,281,844 | 0.79% | 주식 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $24,611,432 | 1,186,665 | 0.73% | 주식 |
| NORTHERN TRUST CORP | $24,398,059 | 1,176,377 | 0.72% | 주식 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24,081,214 | 1,161,100 | 0.71% | 주식 |
| CITIGROUP INC | $21,132,360 | 1,018,918 | 0.62% | 주식 |
| TUDOR INVESTMENT CORP ET AL | $21,106,040 | 1,017,649 | 0.62% | 주식 |
| Swedbank AB | $20,958,994 | 1,010,559 | 0.62% | 주식 |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $19,211,006 | 677,876 | 0.57% | 주식 |
| UBS Group AG | $18,868,401 | 909,759 | 0.56% | 주식 |
| JANE STREET GROUP, LLC | $18,450,221 | 889,596 | 0.54% | 주식 |
| VANGUARD FIDUCIARY TRUST CO | $17,517,170 | 844,608 | 0.52% | 주식 |
| JPMORGAN CHASE & CO | $16,959,200 | 817,890 | 0.50% | 주식 |
| Bank of New York Mellon Corp | $16,627,817 | 801,727 | 0.49% | 주식 |
| ALGERT GLOBAL LLC | $16,161,002 | 779,219 | 0.48% | 주식 |
| Wilmington Savings Fund Society, FSB | $16,054,610 | 566,500 | 0.47% | 주식 |
| BANK OF NOVA SCOTIA | $15,850,607 | 764,253 | 0.47% | 주식 |
| CANADA PENSION PLAN INVESTMENT BOARD | $14,559,480 | 702,000 | 0.43% | 주식 |
| DIMENSIONAL FUND ADVISORS LP | $13,859,558 | 668,303 | 0.41% | 주식 |
| Fundsmith LLP | $13,549,940 | 653,324 | 0.40% | 주식 |
회사 내부자 15 명의 내부자 · 8 임원 · 6 이사
| 내부자 | 역할 | 마지막 활동 | 보유 주식 수 | 매수 12개월 | 매도 12개월 | 순매수/매도 12개월 |
|---|---|---|---|---|---|---|
| Jeffrey Tangney | Chief Executive Officer | 2026년 8월 15일 F | 2,531,955 | 0 | 0 | $0 |
| Matthew Sonefeldt | Chief Financial Officer | 2026년 8월 15일 F | 486,238 | 0 | 0 | $0 |
| Anna Bryson | Chief Financial Officer | 2026년 2월 15일 F | 505,549 | 0 | 0 | $0 |
| Steven L Zatz | President | 2026년 9월 24일 A | 204,291 | 0 | 0 | $0 |
| Siddharth Sitaram | Chief Accounting Officer | 2026년 10월 14일 C | 101,432 | 0 | 9 | $-499,519 |
| Craig Overpeck | Senior Vice President, Commercial Operations | 2024년 5월 16일 S | 108,609 | 0 | 0 | $0 |
| Paul W. Jorgensen | Chief Revenue Officer | 2023년 2월 15일 F | 313,059 | 0 | 0 | $0 |
| Joseph B. Kleine | Chief Commercial Officer | 2022년 1월 12일 C | 441,760 | 0 | 0 | $0 |
| Kira Scherer Wampler | 이사 | 2026년 10월 1일 C | 27,923 | 0 | 9 | $-845,180 |
| Watkin Phoebe L. Yang | 이사 | 2026년 9월 30일 S | 24,744 | 0 | 1 | $-34,456 |
| Regina M. Benjamin | 이사 | 2026년 8월 27일 A | 58,987 | 0 | 0 | $0 |
| Kevin Spain | 이사 | 2026년 8월 27일 A | 11,305 | 0 | 0 | $0 |
| Timothy S Cabral | 이사 | 2026년 8월 27일 A | 11,305 | 0 | 2 | $-793,325 |
| Andreas Stavropoulos | 10% 소유주 | 2021년 6월 28일 C | · | 0 | 0 | $0 |
| Gilbert H Kliman | · | 2022년 8월 2일 D | 449,960 | 0 | 0 | $0 |
SEC 양식 3/4/5 제출 서류 기준 내부자; 순매수/매도는 공개 시장 거래만 해당
ETF 보유 현황 82 ETF 보유
가중치는 직접적인 주식 보유(N-PORT)만 반영합니다. 레버리지 또는 파생 상품 기반 펀드는 표시되지 않은 추가 스왑 노출을 보유할 수 있습니다.
| 펀드 | 비중 | 단위 | 기준일 | 출처 |
|---|---|---|---|---|
| GRPM · Invesco Exchange-Traded Fund Trust | 2.25% | 411,666 SH | 2026년 10월 23일 | 일간 |
| LSEQ · Harbor ETF Trust | 2.02% | 14,749 NS | 2026년 7월 31일 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1.37% | 686,526 NS | 2026년 7월 31일 | N-PORT |
| SMLL · Harbor ETF Trust | 1.35% | 9,053 NS | 2026년 7월 31일 | N-PORT |
| RNIN · EA Series Trust | 1.13% | 98,433 NS | 2026년 7월 31일 | N-PORT |
| MCOW · Pacer Funds Trust | 1.03% | 525 NS | 2026년 7월 31일 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0.83% | 1,385,499 SH | 2026년 10월 23일 | 일간 |
| RFG · Invesco Exchange-Traded Fund Trust | 0.54% | 50,235 SH | 2026년 10월 23일 | 일간 |
| BUL · Pacer Funds Trust | 0.49% | 30,738 NS | 2026년 7월 31일 | N-PORT |
| IHF · iShares Trust | 0.48% | 257,076 SH | 2026년 9월 11일 | 일간 |
| AFMC · First Trust Exchange-Traded Fund VI… | 0.38% | 30,169 NS | 2026년 8월 31일 | N-PORT |
| COWG · Pacer Funds Trust | 0.33% | 349,670 NS | 2026년 7월 31일 | N-PORT |
| CALF · Pacer Funds Trust | 0.32% | 557,810 NS | 2026년 7월 31일 | N-PORT |
| ESUM · Strategy Shares | 0.18% | 15,942 NS | 2026년 7월 31일 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.16% | 20,012 SH | 2026년 10월 23일 | 일간 |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.15% | 132,035 SH | 2026년 8월 19일 | 일간 |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.13% | 30,482 SH | 2026년 10월 23일 | 일간 |
| BKSE · BNY Mellon ETF Trust | 0.12% | 5,010 NS | 2026년 7월 31일 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.12% | 25,655 NS | 2026년 7월 31일 | N-PORT |
| EWUS · iShares Trust | 0.11% | 52,582 SH | 2026년 9월 11일 | 일간 |
| VFQY · VANGUARD WELLINGTON FUND | 0.11% | 25,965 SH | 2026년 8월 19일 | 일간 |
| ESSC · Strategy Shares | 0.10% | 1,770 NS | 2026년 7월 31일 | N-PORT |
| ISCG · iShares Trust | 0.10% | 39,666 SH | 2026년 9월 11일 | 일간 |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0.10% | 33,755 NS | 2026년 7월 31일 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.09% | 74,045 SH | 2026년 10월 23일 | 일간 |
| FSMD · FIDELITY COVINGTON TRUST | 0.08% | 97,882 NS | 2026년 7월 31일 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.08% | 215,901 SH | 2026년 8월 19일 | 일간 |
| PTMC · Pacer Funds Trust | 0.08% | 14,760 NS | 2026년 7월 31일 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0.07% | 1,747,294 SH | 2026년 8월 19일 | 일간 |
| MIDU · Direxion Shares ETF Trust | 0.06% | 1,965 NS | 2026년 7월 31일 | N-PORT |
| IYH · iShares Trust | 0.05% | 77,403 SH | 2026년 9월 11일 | 일간 |
| ESML · iShares Trust | 0.05% | 56,863 SH | 2026년 9월 11일 | 일간 |
| VFVA · VANGUARD WELLINGTON FUND | 0.05% | 21,465 SH | 2026년 8월 19일 | 일간 |
| SMMD · iShares Trust | 0.04% | 69,284 SH | 2026년 9월 11일 | 일간 |
| VHT · VANGUARD WORLD FUND | 0.04% | 362,894 SH | 2026년 8월 19일 | 일간 |
| SMDX · Tidal Trust III | 0.04% | 2,374 NS | 2026년 7월 31일 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.04% | 57,235 NS | 2026년 7월 31일 | N-PORT |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.04% | 14,150 SH | 2026년 10월 23일 | 일간 |
| WSML · iShares Trust | 0.03% | 53,898 SH | 2026년 9월 11일 | 일간 |
| IEUS · iShares Trust | 0.03% | 67,403 SH | 2026년 9월 11일 | 일간 |
| IWS · iShares Trust | 0.03% | 193,300 SH | 2026년 9월 11일 | 일간 |
| VXF · VANGUARD INDEX FUNDS | 0.03% | 1,537,722 SH | 2026년 8월 19일 | 일간 |
| VB · VANGUARD INDEX FUNDS | 0.03% | 3,033,009 SH | 2026년 8월 19일 | 일간 |
| IWR · iShares Trust | 0.02% | 538,960 SH | 2026년 9월 11일 | 일간 |
| RILA · Spinnaker ETF Series | 0.02% | 446 NS | 2026년 7월 31일 | N-PORT |
| WSGE · EA Series Trust | 0.02% | 700 NS | 2026년 7월 31일 | N-PORT |
| PDN · Invesco Exchange-Traded Fund Trust … | 0.02% | 68,821 SH | 2026년 10월 23일 | 일간 |
| LRND · New York Life Investments ETF Trust | 0.02% | 2,967 NS | 2026년 7월 31일 | N-PORT |
| SCZ · iShares Trust | 0.01% | 2,047,043 SH | 2026년 9월 11일 | 일간 |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 2,102,305 SH | 2026년 8월 19일 | 일간 |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.01% | 78,419 SH | 2026년 8월 19일 | 일간 |
| DXUV · Dimensional ETF Trust | 0.01% | 2,526 NS | 2026년 7월 31일 | N-PORT |
| IUSG · iShares Trust | 0.01% | 114,485 SH | 2026년 9월 11일 | 일간 |
| IWD · iShares Trust | 0.01% | 288,768 SH | 2026년 9월 11일 | 일간 |
| IYY · iShares Trust | 0.00% | 5,691 SH | 2026년 9월 11일 | 일간 |
| ITOT · iShares Trust | 0.00% | 179,485 SH | 2026년 9월 11일 | 일간 |
| IWB · iShares Trust | 0.00% | 90,563 SH | 2026년 9월 11일 | 일간 |
| IWV · iShares Trust | 0.00% | 36,814 SH | 2026년 9월 11일 | 일간 |
| DFAC · Dimensional ETF Trust | 0.00% | 99,952 NS | 2026년 7월 31일 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 3,539 NS | 2026년 7월 31일 | N-PORT |
| IEUR · iShares Trust | 0.00% | 334,412 SH | 2026년 9월 11일 | 일간 |
| IDEV · iShares Trust | 0.00% | 905,897 SH | 2026년 9월 11일 | 일간 |
| DFUS · Dimensional ETF Trust | 0.00% | 23,098 NS | 2026년 7월 31일 | N-PORT |
| IEFA · iShares Trust | 0.00% | 4,370,632 SH | 2026년 9월 11일 | 일간 |
| DCOR · Dimensional ETF Trust | 0.00% | 3,112 NS | 2026년 7월 31일 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 10,812 NS | 2026년 7월 31일 | N-PORT |
| IXUS · iShares Trust | 0.00% | 862,826 SH | 2026년 9월 11일 | 일간 |
| TILT · FlexShares Trust | 0.00% | 158 NS | 2026년 7월 31일 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4,200,411 SH | 2026년 8월 19일 | 일간 |
| VXUS · VANGUARD STAR FUNDS | 0.00% | 7,970,190 SH | 2026년 8월 19일 | 일간 |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 1,396,695 SH | 2026년 8월 19일 | 일간 |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.00% | 598,294 SH | 2026년 8월 19일 | 일간 |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0.00% | 5,431,499 SH | 2026년 8월 19일 | 일간 |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.00% | 22,610 SH | 2026년 8월 19일 | 일간 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 10,642 SH | 2026년 8월 19일 | 일간 |
| VSGX · VANGUARD WORLD FUND | 0.00% | 95,335 SH | 2026년 8월 19일 | 일간 |
| ESGV · VANGUARD WORLD FUND | 0.00% | 29,384 SH | 2026년 8월 19일 | 일간 |
| IJH · iShares Trust | · | 4,694,508 SH | 2026년 9월 11일 | 일간 |
| IJK · iShares Trust | · | 774,827 SH | 2026년 9월 11일 | 일간 |
| XJH · iShares Trust | · | 18,322 SH | 2026년 9월 8일 | 일간 |
| ISCB · iShares Trust | · | 5,605 SH | 2026년 9월 11일 | 일간 |
| SMLF · iShares Trust | · | 103,220 SH | 2026년 9월 11일 | 일간 |
DOCS 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
12개월 목표 주가
18 명의 애널리스트 · 2026-10-24평균 목표 $31.11 -6.8%
동종 기업 비교(GICS 하위 산업) 주요 지표 대 섹터 동종 기업
회계연도 기준, 각 회사의 마지막 회계연도 말 종가 기준 가격입니다.
| 티커 | 시가총액 | P/E | 매출 YoY | 순이익률 | ROE | 매출 총이익률 |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | · |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | · | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | · |
| GDRX | · | 30.1 | 0.57% | 3.8% | 4.8% | · |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | · |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | · |
| PHR | · | 335.8 | 14.5% | 0.48% | 0.73% | · |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
중요한 지표를 선택하세요. 상단의 전체 기본 정보에서 원하는 행 옆의 +를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.